Safety and antiviral activity of albinterferon alfa-2b dosed every four weeks in genotype 2/3 chronic hepatitis C patients (Q42978321)

From Wikidata
Jump to navigation Jump to search
scientific article published on 7 May 2008
edit
Language Label Description Also known as
English
Safety and antiviral activity of albinterferon alfa-2b dosed every four weeks in genotype 2/3 chronic hepatitis C patients
scientific article published on 7 May 2008

    Statements

    Safety and antiviral activity of albinterferon alfa-2b dosed every four weeks in genotype 2/3 chronic hepatitis C patients (English)
    Vincent G Bain
    Kelly D Kaita
    Paul Marotta
    Eric M Yoshida
    Mark G Swain
    Robert J Bailey
    Keyur Patel
    Patrick W Cronin
    Erik Pulkstenis
    John G McHutchison
    G Mani Subramanian
    701-706

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit